Aspergillosis in a patient receiving temozolomide for the treatment of glioblastoma

Case Reports in Oncology

Volumn 6, Issue 2, 2013, Pages 410-415

  Munhoz, Rodrigo Ramella ^a   Picarelli, Andrea Arvai Pereira ^a   Mitteldorf, Cristina Aparecida Troques ^a   Feher, Olavo ^a  

^a HOSPITAL SÍRIO LIBANÊS   (Brazil)

Author keywords

Glioblastoma; Opportunistic infections; Pulmonary aspergillosis; Temozolomide

Indexed keywords

AMLODIPINE; COTRIMOXAZOLE; DEXAMETHASONE; GALACTOMANNAN; GLICLAZIDE; METFORMIN; OMEPRAZOLE; SITAGLIPTIN; TEMOZOLOMIDE; VORICONAZOLE;

AGED; ARTICLE; ASPERGILLUS FUMIGATUS; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; COUGHING; CRANIOTOMY; CRYPTOCOCCUS NEOFORMANS; DEEP VEIN THROMBOSIS; DYSPNEA; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLIOBLASTOMA; HEMOPTYSIS; HISTOPLASMA; HUMAN; HUMAN TISSUE; IMAGE GUIDED BIOPSY; LEG EDEMA; LUNG ASPERGILLOSIS; LUNG EMBOLISM; LUNG PARENCHYMA; LYMPHOCYTOPENIA; MULTIMODALITY CANCER THERAPY; NAUSEA; PRIORITY JOURNAL; RADIATION INJURY; SPUTUM; THORAX PAIN; VERY ELDERLY;

EID: 84885650366     PISSN: None     EISSN: 16626575     Source Type: Journal    
DOI: 10.1159/000354429     Document Type: Article

References (16)

1. Central Brain Tumor Registry of the United States: CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2004-2007. Hinsdale, IL, CBTRUS, 2011. www.cbtrus.org.
2. Fisher JL, Schwartzbaum JA, Wrensch M, Wiemels JL: Epidemiology of brain tumors. Neurol Clin 2007;25:867-890.
3. Stupp R, Mason WP, van den Bent MJ, et al: Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005;352:987-996.
4. Stupp R, Hegi ME, Mason WP, et al: Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 2009;10:459-466.
5. Stupp R, Dietrich PY, Osternmann KS, et al: Promising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide, followed by adjuvant temozolomide. J Clin Oncol 2002;20:1375-1382.
6. Su YB, Sohn S, Krown SE, et al: Selective CD4+ lymphopenia in melanoma patients treated with temozolomide: a toxicity with therapeutic implications. J Clin Oncol 2004;22:610-616.
7. Schwarzberg AB, Stover EH, Sengupta T, et al: Selective lymphopenia and opportunistic infections in neuroendocrine tumor patients receiving temozolomide. Cancer Invest 2007;25:249-255.
8. Grossman SA, Ye X, Lesser G, et al: Immunosuppression in patients with high-grade gliomas treated with radiation and temozolomide. Clinical Cancer Res 2011;17:5473-5480.
9. Cohen MH, Johnson JR, Pazdur R: Food and Drug Administration drug approval summary: temozolomide plus radiation therapy for the treatment of newly diagnosed glioblastoma multiforme. Clin Cancer Res 2005;11:6767-6771.
10. Yaman E, Coskun U, Ozturk B, et al: Opportunistic cytomegalovirus infection in a patient receiving temozolomide for treatment of malignant glioma. J Clin Neurosci 2009;16:591-592.
11. Meije Y, Lizasoain M, Garcia-Reyne A, et al: Emergence of cytomegalovirus disease in patients receiving temozolomide: report of two cases and literature review. Clin Infect Dis 2010;50:e73-e76.
12. Limper AH, Knox KS, Sarosi GA, et al: An official American Thoracic Society statement: treatment of fungal infections in adult pulmonary and critical care patients. Am J Respir Crit Care Med 2011;183:96.
13. Segal BH: Aspergillosis. N Engl J Med 2009;360:1870-1884.
14. Pfeiffer CD, Fine JP, Safdar N: Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-Analysis. Clin Infect Dis 2006;42:1417.
15. Sterigipoulou T, Meletiadis J, Roilides E, et al: Host-dependent patterns of tissue injury in invasive pulmonary aspergillosis. Am J Clin Pathol 2007;127:349-355.
16. Wick W, Wick A, Schulz JB, et al: Prevention of irradiation-induced glioma cell invasion by temozolomide involves caspase 3 activity and cleavage of focal adhesion kinase. Cancer Res 2002;62:1915-1919.